Demonstration of a fusion mechanism between a fluid bactericidal liposomal formulation and bacterial cells  by Sachetelli, Sébastien et al.
Demonstration of a fusion mechanism between a £uid bactericidal
liposomal formulation and bacterial cells
Se¤bastien Sachetelli a, Hayssam Khalil a, Tao Chen a;b, Christian Beaulac a;b,
Serge Se¤ne¤chal a, Jacqueline Lagace¤ a;b;*
a Department of Microbiology and Immunology, Faculty of Medicine, University of Montreal, C.P. 6128, Succ. Centre-Ville,
Montreal, Que. H3C 3J7, Canada
b Theralipids Inc., 6100 Royalmount Avenue, Montreal, Que. H4P 2R2, Canada
Received 18 May 1999; received in revised form 30 September 1999; accepted 19 October 1999
Abstract
It was previously demonstrated that fluid liposomal-encapsulated tobramycin, named Fluidosomes, was successful in
eradicating mucoid Pseudomonas aeruginosa in an animal model of chronic pulmonary infection, whereas free antibiotic did
not reduce colony-forming unit (CFU) counts (C. Beaulac et al., Antimicrob. Agents Chemother. 40 (1996) 665^669;
C. Beaulac et al., J. Antimicrob. Chemother. 41 (1998) 35^41). These liposomes were also shown to be bactericidal in in vitro
tests against strong resistant P. aeruginosa strains. To define the mechanism by which Fluidosomes work, negative staining,
immunoelectron microscopy, fluorescence activated cell sorting (FACS) and lipid-mixing studies were performed. All the
lines of evidence suggest that Fluidosomes fuse with bacterial cells leading to a marked increase of tobramycin in the
cytoplasm of a resistant bacteria (minimal inhibitory concentration (MIC) s 64 Wg/ml). The time needed to reach the
maximal fusion rate was about 5 h for the resistant strain comparatively to much shorter time for the sensitive strain. The
specific characteristics of Fluidosomes could help overcome bacterial resistance related to permeability barrier and even
enzymatic hydrolysis considering the importance of synergy in the whole process of antibiotic resistance. ß 2000 Elsevier
Science B.V. All rights reserved.
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1. Introduction
Chronic pulmonary infections with Pseudomonas
aeruginosa and other related strains like Burkholderia
cepacia are considered as the most important factor
determining the prognosis of cystic ¢brosis (CF) pa-
tients [1^3]. These bacteria are known for their very
low non-speci¢c permeability and/or the presence of
membrane-associated energy-driven e¥ux systems
that make them resistant to the majority of antibi-
otics [4]. Other mechanisms of resistance, like enzy-
matic inactivation of the drug and alteration of its
molecular target, can work synergistically with pre-
vious mechanisms [5^8]. Another cause of resistance
to antibiotics that is largely underestimated is a tran-
sitory and unstable phenomenon of decreased mem-
brane permeability that appears and is maintained
only in the presence of the antibiotic [9]. Conse-
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quently, e⁄cient therapy against P. aeruginosa in CF
remains di⁄cult and controversial leading to pro-
gressive pulmonary damage and, eventually to death
[2,3].
To increase the bactericidal e⁄cacy of antibiotics,
di¡erent liposomal formulations were developed in
our laboratory with the aim of promoting e¡ective
interactions between bacteria and encapsulated
drugs, increasing the lifetime of the encapsulated
antibiotics and reducing systemic drug absorption
[10]. Tobramycin encapsulated in a negatively
charged liposomal formulation presenting a low
gel^liquid crystalline transition temperature (TC)
9 37‡C succeeded, for the ¢rst time, in eradicating
mucoid P. aeruginosa in an animal model of chronic
pulmonary infection [11]. This £uid liposomal encap-
sulated tobramycin, named Fluidosomes, was later
shown to be e¡ective against all the other bacterial
strains tested: Stenotrophomonas maltophilia, Burk-
holderia cepacia, Escherichia coli and Staphylococcus
aureus [12]. To investigate further how Fluidosomes
interact with bacteria, we proceeded in performing
negative staining, immunoelectron microscopy, £uo-
rescence-activated cell sorting (FACS) and lipid-mix-
ing studies.
2. Materials and methods
2.1. Bacterial strains
A clinical and a reference strain were used in this
study. P. aeruginosa 429 is a clinical strain obtained
from a patient with cystic ¢brosis (Sainte-Justine
Hospital, Montre¤al, Que¤., Canada) which has an
minimal inhibitory concentration (MIC) for tobra-
mycin of 64 Wg/ml. A P. aeruginosa 429 susceptibility
pro¢le with the 24 aminoglycosides for which MICs
were performed shows resistance values between 64
and 512 Wg/ml. This strain was also probed negative
by DNA hybridization to all 14 aminoglycoside re-
sistance genes tested (Antibiotic Screening and Eval-
uation, Schering-Plough, New Jersey, USA) suggest-
ing permeability resistance that was con¢rmed by
disk tests. Strain 429 shows small colony morphol-
ogy and a rate of growth corresponding to only
about 29% of that of the reference strain. The refer-
ence strain, P. aeruginosa ATCC 25619, was ob-
tained from the American Type Culture Collection
(ATCC), Rockville, MD). This strain is not resistant
to tobramycin (MIC6 1 Wg/ml). Both strains were
stored in brain heart infusion broth supplemented
with 10% glycerol. For the experiments, a 17-h cul-
ture of these organisms in proteose peptone no. 2
broth (Difco Laboratories, Detroit, MI) was pre-
pared.
2.2. Fluidosomes
Fluidosomes are liposomes composed of dipalmi-
toyl phosphatidylcholine (DPPC) and dimiristoyl
phosphatidylglycerol (DMPG) (Avanti polar lipids,
Alasbaster, AL) in a ratio of 18:1 (w/w) which
have an overall low gel^liquid crystalline transition
temperature (TC6 37‡C). They are prepared by
Theralipids (Ville Mont-Royal, Que¤., Canada) using
the dehydration^rehydration method as previously
described [11,12]. Brie£y, appropriate amounts of
both phospholipids are dissolved in chloroform in a
round-bottom £ask. A lipid ¢lm is then obtained by
rotoevaporation (Bu«chi Rotavapor) at 65‡C under
vacuum (Bu«chi vacuum controller). The lipids are
then re-dissolved in phosphate-bu¡ered saline (PBS)
1:20, freeze-dried at 4‡C (Virtis Genesis 12 EL Con-
sole freeze dryer, Canberra Parkard, Toronto, Can-
ada) and kept at 370‡C until use. When Fluido-
somes containing tobramycin are needed, 3.75 ml
of tobramycin sulfate (Nebcin, Eli Lilly, Toronto,
Ont., Canada) at a concentration of 40 mg/ml was
added to the freeze-dried liposomal preparation. The
solution was incubated 60 min at 65‡C with vigorous
vortexing every 10 min and extruded successively
through polycarbonate membranes of 1.0, 0.6 and
0.4 Wm. Fluidosomes without tobramycin were pre-
pared similarly, but PBS was used instead of the
antibiotic. Unencapsulated tobramycin was then re-
moved by centrifugations (2U5000Ug, 30 min 4‡C)
and the ¢nal liposomal pellet was resuspended in
PBS. The quanti¢cation of tobramycin in Fluido-
somes was performed by HPLC analysis as previ-
ously described [11,12].
2.3. Antibiotic penetration assessment by
immunoelectron microscopy
For these experiments, the P. aeruginosa strain 429
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was used. Brie£y, a 17-h culture of this clinical strain
was collected and a solution with an optical density
(OD) of 0.04 (660 nm) was made in fresh proteose
peptone no. 2. Amounts of 29 ml of this solution
were then added to 50-ml tubes. Fluidosomes or
free tobramycin at a ¢nal concentration of 30 Wg/
ml (half the MIC of the bacteria) or PBS as a control
were then added and incubated at 37‡C with agita-
tion (250 rpm). Two-ml samples were taken after 0,
1, 2, 3 and 6 h of incubation and processed for elec-
tron microscopy. Brie£y, the samples were centri-
fuged and the pellet resuspended in a solution of
electron microscopy grade glutaraldehyde and para-
formaldehyde (Sigma, St. Louis, MI) at percentages
of 0.1 and 4%, respectively, prepared in 0.1 M of
cacodylate bu¡er, pH 7.0. The cells were incubated
for a period of 2 h at room temperature in the ¢x-
ation solution. After ¢xation, the cells were washed
in cacodylate bu¡er 0.1 M containing 3% sucrose (w/
v) and processed for embedding in Spurr resin. Ul-
tra-thin cuts of the samples were made and prepared
for immunogold labeling using a standard procedure
[13]. To detect the presence of tobramycin inside the
bacteria, antibodies against tobramycin (Cerderlane,
Ont.) were used and revealed with colloidal gold
(10 nm) coupled to protein A/G prepared as previ-
ously described [14]. Samples were analyzed using a
Hitachi transmission electron microscope (Hitachi
7100).
2.4. Analysis of fusion between bacteria and
Fluidosomes by negative staining
Bacteria (P. aeruginosa 429) were incubated with
Fluidosomes following the same procedure as de-
scribed above. A sample was taken 1 h after incuba-
tion and processed for visualization by negative
staining. A drop of the bacterial suspension was lay-
ered on formvar-coated copper grid and incubated
1 min at room temperature to allow the bacteria to
adhere to the grid. Excess liquid was absorbed and a
drop of phosphotungtenic acid (PTA) at 1% (Elec-
tron Microscopy Sciences, Fort Washington, PA)
was added. The grid was incubated 1 min, excess
liquid was absorbed and the sample was visualized
by electron microscopy.
2.5. Bacteria and liposome fusion as measured by
lipid-mixing assay
Fluidosomal fusion with bacteria was monitored
by a lipid-mixing assay based on the extent of
resonance energy transfer (RET) between the lipid
headgroup-labeled probes, 1,2-dioleoyl-sn-glycero-
3-phosphoethanolamine-N-(lissamine Rhodamine B
sulfonyl) (Rh-PE) and 1,2-dioleoyl-sn-glycero-3-
phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadia-
zol-4-yl) (NBD-PE), as described by Struck et al.
[15]. All £uorescence measurements were carried
out with a Perkin-Elmer LS-50B £uorescence spec-
trophotometer. In a typical experiment, the NBD/
Rh-labeled Fluidosomes were prepared as the meth-
od described previously containing both NBD-PE
and Rh-PE at 0.2 mol% each. The NBD/Rh-labeled
vesicles (36 WM) were mixed with bacteria
(OD660 = 0.6) and incubated at 37‡C under agitation
(250 rpm). RET e⁄ciency was monitored by measur-
ing wavelength scans of the reaction mixtures £uo-
rescence. At di¡erent time points, 100-Wl aliquots
were mixed with an equal volume of HEPES bu¡er
(pH 7.4, 20 mM HEPES and 150 mM NaCl) in a
96-well plate, and the £uorescence intensity was de-
termined in a wavelength range from 500 to 610 nm
under steady-state excitation at 475 nm (maximal
excitation peak for NBD). The fusion of NBD/Rh-
labeled Fluidosomes with bacteria resulted in probe
dilution (lipid-mixing) and an increased distance be-
tween the NBD-PE and Rh-PE, thereby decreasing
RET e⁄ciency and decreasing Rh-£uorescence inten-
sity.
The Rh-£uorescence decrease due to fusion was
measured and used for calculation of degree of fu-
sion. In brief, the NBD/Rh-labeled Fluidosomes
were prepared according to the method described
previously containing both NBD-PE and Rh-PE at
0.2 mol% each. The NBD/Rh-labeled vesicles
(58 WM) were quickly mixed with bacteria
(OD660 = 0.6) in a cuvette under controlled temper-
ature and continuous stirring. The ¢nal incubation
volume in all measurements was 2 ml. Continuous
monitoring of rhodamine £uorescence (590 nm) were
done at an interval of 1 min under steady-state ex-
citation at 475 nm (NBD maximal excitation). The
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¢nal £uorescence intensity (Fmax) which represents
maximal £uorescent lipid probe dilution in each sam-
ple was determined following the solubilization of
vesicles with SDS detergent (0.2% volume). The per-
centage of fusion (or lipid dilution) was calculated
using the following equation:
% Fusion  Ft3Fo
Fmax3Fo
U100
where Ft is the £uorescence intensity at each time
point; Fo is the initial £uorescence intensity. Each
experiment for the given conditions was repeated
three times.
2.6. Labeling of Fluidosomes with PHK2-GL
To evaluate fusion of Fluidosomes with bacteria
by £ow cytometry, Fluidosomes were labeled with
PKH2-GL using the PKH2-GL labeling kit (Sigma,
St. Louis, MI). PHK2-GL is a probe often used to
study interactions between biological membranes
[16,17]. This probe is a £uorescent cell linker dye
containing aliphatic carbon tails which insert them-
selves in membranes. It possesses similar spectral
characteristics as FITC. Brie£y, freeze-dried Fluido-
somes were rehydrated with phosphate bu¡ered sa-
line (PBS), pH 7.2 as previously described [11,12].
The ¢nal liposomal pellet was then used for the label-
ing procedure. Labeling was e¡ectuated following the
manufacturer’s instructions, but with small modi¢ca-
tions. A 1-ml aliquot was taken and centrifuged
30 min at 6000Ug under 4‡C. The pellet was then
resuspended in 1 ml of diluent A (Sigma, St. Louis,
MI). Diluent A is a solution contained in the kit used
for the labeling procedure. Eight Wl of PKH2-GL
was then added for a ¢nal concentration of
4U1036 M. The volume was then completed to
2 ml with diluent A. The PKH-liposomal solution
was incubated for 5 min at room temperature with
circular agitation. Following the incubation, 2 ml
of bovine serum albumin at 1% (w/v) in PBS was
added and the solution was further incubated for
1 min with agitation to stop the labeling reaction.
Fluidosomes were then washed twice with PBS by
centrifuging at 5000Ug for 30 min under 4‡C to
remove any free PKH. Labeling e⁄ciency was on
average 95% as determined by £ow cytometric anal-
ysis.
2.7. Flow cytometric analysis of fusion using
PKH2-GL
Integration of Fluidosomes to bacterial cells was
demonstrated in £uorescence-activated cell sorting
(FACS) analysis, using the £uorescent marker
PKH2-GL. P. aeruginosa 429 or ATCC 25619 were
incubated for 17 h in proteose peptone broth no 2. A
solution of 0.3 of OD (660 nm) was then made. The
solution was centrifuged and the cell pellet resus-
pended in RPMI supplemented with 2.5% fetal calf
serum for washing. The ¢nal cell pellet was resus-
pended in RPMI supplemented with 2.5% fetal calf
serum to obtain the same initial concentration.
RPMI was used because it was determined by earlier
experimentation to be the best medium for reducing
background £uorescence of P. aeruginosa due to sid-
erophore production. Aliquots of 18 ml were then
taken and transferred to conical tubes of 50 ml (Sar-
stedt, St. Laurent, Que¤., Canada). Bacteria were in-
cubated either with 200 Wl of Fluidosomes labeled
with PHK2-GL, 200 Wl of PBS (negative control)
or 80 Wl of free PKH-2GL (positive control) to ob-
tain a ¢nal concentration of 4U1036 M. PBS was
then added to complete the volume to 20 ml and
the tubes were incubated at 37‡C with agitation
(250 rpm). Tobramycin was not encapsulated in
Fluidosomes in order to avoid bacterial cell killing.
Based on preliminary studies, 2-ml samples were tak-
en after 10 min, 0.5, 1, 2, 3, 4, 5 and 6 h of incuba-
tion. Fluidosomes and free PKH2-GL were sepa-
rated from the bacteria by centrifugation through a
sucrose cushion of 21% (w/v) in PBS. The recovered
bacterial pellet was washed twice in PBS and the
¢nal cell pellet was ¢xed with 300 Wl of 2% para-
formaldehyde diluted in PBS for FACS analysis.
3. Results
3.1. Determination of tobramycin penetration with
immunocytochemistry
To try to understand how Fluidosomes succeed in
showing strong bactericidal activity against resistant
bacteria with a quantity of antibiotic 9 50% of the
MIC [12], kinetic studies with P. aeruginosa 429 were
performed as previously described [12] to investigate
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the mode of interaction of Fluidosomes. This strain
was selected because of its strong permeability resis-
tance to tobramycin corresponding to 64 Wg/ml. Fol-
lowing electron microscopic observations performed
on negative stained samples 1 h after contact of
Fluidosomes with P. aeruginosa 429, it could be ob-
served that Fluidosomes interact very closely with
the outer membrane of the bacteria (Fig. 2, dark
spheres). Thickenings of the outer membrane were
observed suggesting fusion of the liposomes with
Fig. 1. Detection of tobramycin inside bacterial cells by immunogold labeling. (A) Pseudomonas aeruginosa 429 incubated 6 h with
Fluidosomes. (B) Pseudomonas aeruginosa 429 incubated 6 h with free tobramycin. Magni¢cation: A, U41 126; B, U36 720.
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the bacterial membranes which could explain the in-
creased penetration of antibiotic with Fluidosomes
inside bacterial cells (see arrow on Fig. 2).
To assess the penetration of tobramycin inside the
bacterial cells, strain 429 was incubated with free
tobramycin, Fluidosomes or PBS. Samples were tak-
en after 0, 1, 2, 3 and 6 h post-treatment. Immuno-
gold techniques were used to reveal the presence of
tobramycin. No signi¢cant di¡erences were observed
in the penetration of antibiotic between encapsulated
and free tobramycin after 0^3 h of incubation (data
not shown). However, after 6 h of incubation, a no-
ticeable di¡erence could be seen. In longitudinal bac-
terial sections, up to 23 gold particles could be de-
tected in bacteria exposed to Fluidosomes (Fig. 1A),
whereas less than a mean of two gold particles were
found in the cytoplasm of cells treated with free anti-
biotic (Fig. 1B). Statistical analysis of colloidal gold
labeling after 6 h of incubation in longitudinal bac-
terial sections showed an average of 9.54 þ 4.34 gold
particles/Wm2 in bacteria exposed to Fluidosomes,
whereas only 1.20 þ 1.22 gold particles/Wm2 were
enumerated in longitudinal sections of bacteria incu-
bated with free tobramycin (P6 0.001). The PBS
control gave an average labeling of 0.51 þ 0.82 gold
particles/Wm2 in longitudinal sections of bacterial
cells. Because transversal sections represent only
about 33% of the longitudinal section surface of
P. aeruginosa cells, only longitudinal sections were
selected for enumeration of gold particles to assure
the reproducibility of the counts between the di¡er-
ent groups of cells. Background labeling, which con-
sisted of gold particles not associated with bacteria
or liposomes, was, respectively, of 1.96 þ 0.19, 0.25 þ
0.12 and 0.02 þ 0.02 gold particles/Wm2 in thin sec-
tions for Fluidosomes, free tobramycin and PBS con-
trol.
3.2. Analysis of fusion by £ow cytometry
To verify whether the interaction of Fluidosomes
with the bacteria implicates an integration of liposo-
mal phospholipids in bacterial membranes by fusion,
FACS studies using PKH-2GL, a £uorescent lipo-
philic marker, were performed. Labeled Fluidosomes
without antibiotic, were incubated with P. aeruginosa
429 (MIC 64 Wg/ml) and the reference strain ATCC
25619, displaying no resistance to tobramycin. Anti-
biotic was not encapsulated in Fluidosomes to avoid
bacterial cell killing. After 10 min, 0.5, 1, 2, 3, 4, and
6 h of incubation, bacteria were separated by centri-
fugation through a sucrose cushion and washed. Fu-
Fig. 2. Interaction of Fluidosomes with Pseudomonas aeruginosa 429 cells as observed by negative staining with PTA. Magni¢cation:
U50 561.
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sion was assessed by the integration of phospholipid-
PKH2-GL in bacterial cells as demonstrated by £ow
cytometry studies (Fig. 3). Interaction with the non-
resistant strain was observed within 10 min of con-
tact with Fluidosomes reaching a maximum signal of
61.70% of average £uorescent cells after 30 min and
decreasing afterwards (Fig. 3A). The pattern ob-
served with the resistant strain, P. aeruginosa 429,
Fig. 3. Flow cytometry histograms of Pseudomonas aeruginosa strains ATCC 25619 (A) and 429 (B) incubated with Fluidosomes. T,
time (h); CTRL, negative control; PKH, Fluidosomes labeled with PKH. The percentages of £uorescent cells for the negative control
and bacteria exposed to PKH2-GL are indicated on the ¢gure. The x-axis represents £uorescence intensity and the y-axis cell number.
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was strongly delayed. Indeed, after 10 min of con-
tact, no signi¢cant di¡erence was observed between
the control (bacteria not exposed to labeled Fluid-
osomes) and bacteria incubated with liposomal
PKH2-GL. As time progressed, the percentage of
£uorescent bacteria increased gradually to reach a
maximum of 38.60% after 5 h of incubation with
liposomal PKH2-GL (Fig. 3B), strengthening the
idea of fusion between the liposomes and the bacte-
rial cells as suggested by electron microscopy studies.
Positive controls, which consisted of bacteria marked
with free PKH2-GL, were not put on the ¢gures for
simplicity, but were in the range of 70^95% of £uo-
rescence for the duration of the experiments. This
control assured us that PKH2-GL was compatible
with bacterial membrane. All studies were repeated
at least three times with the same results for a given
strain.
3.3. Monitor and quantify fusion by lipid-mixing
assay
It has been reported that the lipid-mixing assay, in
general, gives a more reliable measurement of mem-
brane fusion since the £uorescence intensity changes
are directly related to the distance between NBD and
Rh, but not to vesicular aggregation and lipid-ex-
change [15,18,19]. This assay has been widely used
for study of membrane fusion [20^22]. Therefore, the
fusion of Fluidosomes with bacteria was further con-
¢rmed by the lipid-mixing assay with Rh-PE and
NBD-PE as £uorescent probes. Fig. 4 represents
the typical £uorescence emission scan pro¢les of
Fluidosome^bacteria fusions monitored by spectro-
£uorometer with a constant excitation at 475 nm
(excitation peak of NBD). As time increased, £uores-
cence intensity of Rh (590 nm) decreased and NBD
signal (520 nm) was increased. It indicates that a
signi¢cant fusion occurred when Fluidosomes were
mixed with bacteria and incubated at 37‡C. In con-
trol experiments with either Fluidosomes or bacteria,
or a mixture of NBD/Rh-labeled Fluidosomes and
non-labeled Fluidosomes, no £uorescence signal
changes were detectable under the same experimental
conditions as for £uidosomal fusion with bacteria
(data not shown).
The fusion of Fluidosome^bacteria was tempera-
ture dependent. There were no signi¢cant Rh-£uores-
Fig. 4. Fluorescence emission scans of a mixture of Fluido-
somes and intact bacteria (P. aeruginosa 25619) at 37‡C in a
wavelength range of 510^610 nm. Fusion of Fluidosomes with
bacteria resulted in NBD £uorescence increase and Rh £uores-
cence decrease (resonance energy transfer e⁄ciency decrease
during fusion). Bacteria grown to an OD660 of 0.6 in LB me-
dium were then mixed with 36.5 WM of NBD/Rh-labeled Fluid-
osomes. Fluorescence emission intensity was monitored at dif-
ferent time points using an LS-50b spectro£uorometer
(excitation at 475 nm, slit width 7 nm). The emission scans
were corrected from bacterial background at the corresponding
time points.
Table 1
Permeability, MIC and degree of fusion of wild-type and resistant P. aeruginosa strains with Fluidosomes
Strain Permeability MIC to free tobramycin (Wg/ml) (%) Fusion of Fluidosomes
FACS Lipid mixing
25619 High 0.1 61.7 55 þ 8
429 Low 64 38.6 29 þ 5
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cence decrease at 4‡C for both wild-type and drug-
resistant bacteria (Fig. 5, plot A; a similar observa-
tion obtained for P. aeruginosa strain 429, but data
not shown). The rate and degree of fusion were also
dependent on the nature of bacterial strain. The lipo-
somal fusion with non-resistant strain, such as
P. aeruginosa 25619, was relatively fast, occurring
earlier in accelerating phase at 1 h and reaching
slower phase at 2 h (Fig. 5, plot C). While for the
drug-resistant strain of P. aeruginosa 429, the fusion
was delayed substantially and was much lower (Fig.
5, plot B). Table 1 summarizes the degree of £uid-
osomal fusion with both non-resistant and resistant
P. aeruginosa strains with two di¡erent assays
(FACS and lipid mixing).
4. Discussion
Using P. aeruginosa 429, it was previously demon-
strated that the use of a quantity of tobramycin cor-
responding to only 50% of the MIC of this bacteria,
succeeded in reducing the number of CFU by a fac-
tor of 84 times compared to the same quantity of free
tobramycin 6 h after the addition of antibiotic [12].
These results strongly suggest that the mode of ac-
tion of Fluidosomes is related to an uncommon way
of penetration in bacterial cells, since a normal dif-
fusion process cannot explain why a quantity of en-
capsulated antibiotic corresponding to only 50% of
the MIC can kill bacteria, whereas the same quantity
of free antibiotic is ine¡ective. Unfortunately, it was
Fig. 5. Fusion of Fluidosomes with intact bacteria monitored by rhodamine £uorescence decrease at 590 nm resulting from resonance
energy transfer e⁄ciency decrease (see text). Bacteria grown to an OD660 of 0.6 in LB medium were then mixed with 82.5 WM of
NBD/Rh-labeled Fluidosomes. Rhodamine emission at 590 nm (slit width 5 nm) was continuously monitored using an LS-50b spectro-
£uorometer (excitation at 475 nm, slit width 5 nm). Dots were experimental measurements and the solid lines were calculated by re-
gression. A, at 4‡C for P. aeruginosa 25619 (wild-type); B, at 37‡C for P. aeruginosa 429 (resistant strain); C, at 37‡C for P. aerugino-
sa 25619.
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impossible to reproduce such killing curves with
strain ATCC 25619 used as control in FACS studies,
since this latter strain is sensitive to tobramycin. This
strain cannot stay alive in the presence of a minimal
concentration of antibiotic, which is essential for
measuring a modi¢cation of growth following con-
tact with free and encapsulated antibiotic. On the
other hand, the sensitivity of the control strain to
tobramycin was essential to perform comparative
FACS studies with the resistant strain.
Using the following methodologies, negative stain-
ing coloration for EM, immunoelectron microscopy,
FACS and lipid-mixing assay, we reproduced, in the
present work, the kinetic study with strain 429 with
the aim to elucidate its mode of interaction with
Fluidosomes. EM observations of negative staining
coloration of bacterial cell grown in the presence of
Fluidosomes (dark spheres in Fig. 1A) show that
these latter interact very closely with bacterial mem-
branes (dark spheres in Fig. 1A). Immunogold colo-
ration of ultra-thin sections done with strain 429
showed the presence of greater quantities of tobra-
mycin in bacterial cells incubated with Fluidosomes
compared with the free antibiotic (P6 0.001) demon-
strating increased penetration of the antibiotic when
encapsulated (Fig. 1A,B).
Even if the di¡erence of labeling of bacteria ex-
posed to Fluidosomes and free tobramycin was
very signi¢cant (P6 0.001), one could expect a
more important labeling if we take into account the
strong bactericidal e⁄cacy of Fluidosomes compared
to free tobramycin in previous studies [12]. In fact,
we found only a few gold particles into each Fluid-
osomes (data not shown), this means that only a low
percentage of molecules of tobramycin are revealed
by antibodies/colloid gold particles coupled to pro-
tein A/G. Despite this fact, a very signi¢cant di¡er-
ence in labeling could be observed between bacteria
exposed to Fluidosomes and free tobramycin.
To investigate further the interaction of Fluido-
somes with bacterial cells and to determine if the
increased penetration of tobramycin was associated
with incorporation of liposomal phospholipids in
bacterial cells, PKH2-GL was used in cytometry
studies. PKH2-GL has the characteristic of inserting
itself into membranes due to its aliphatic properties
by use of Zyn-linker technology [16,17]. Because of
its inherent insolubility in aqueous environments, the
probe is trapped once incorporated into the mem-
brane, making it a reliable tracer for fusion and/or
integration analysis. Since the probe cannot by itself
disincorporate or di¡use from the liposomes to the
bacteria using the aqueous environment as an inter-
mediate, this implies that the results observed can
only be explained by a direct incorporation of lipo-
somes or liposomal phospholipids in the outer mem-
brane. The cytometry results show that the speed of
incorporation of the markers in the two bacteria was
very di¡erent. The integration of Fluidosomes in the
sensitive bacteria (ATCC 25619) was already impor-
tant 10 min after the addition of liposomes, reaching
a maximum value of 61.70% of bacteria containing
liposomal-PHK2-GL after 30 min (Fig. 3A). The
maximal incorporation was achieved after only 5 h
of incubation with the resistant strain (P. aeruginosa
429), at which time 38.60% of bacteria contained
liposomal-PKH2-GL (Fig. 3B). It is signi¢cant that
for the resistant strain, optimal interaction took place
after 5 h of incubation (Fig. 3B) which is in accord-
ance with the beginning of the bactericidal e¡ect ob-
served after 6 h in previous kinetic studies following
interaction of Fluidosomes with P. aeruginosa 429
[4]. The FACS study also showed that after 6 h of
incubation, two di¡erent populations of cells could
be distinguished in relation to the incorporation of
liposomal-PHK2-GL (Fig. 3A,B). This phenomenon
was probably due to the fact that the concentration
of liposomal-PKH2-GL stayed the same throughout
the whole experiment, whereas as time progressed,
liposomal-PKH2-GL was incorporated or fused
with bacteria. A £uorescent population of bacteria
appeared, meanwhile bacterial growth proceeded
and an increasing number of non-£uorescent bacteria
repopulated the non-£uorescent pool. This eventually
created two populations of cells, which were seen
after 6 h of incubation in the two strains tested.
Eventually, if additional liposomal-PKH2-GL would
be available in the system, one could hypothesize
that all bacteria present would be £uorescent. The
di¡erent levels of liposomal-PKH2-GL incorpora-
tions in function of time between the two strains
imply that membrane impermeability a¡ects the ini-
tiation time, the rapidity and the rate of fusion. But
even if the interaction was slowed with the resistant
strain, the processes of fusion between the liposomes
and the bacterial cells was still important and su⁄-
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cient to explain the bactericidal activity previously
observed with Fluidosomes and P. aeruginosa 429
[12]. Finally, the necessity to perform the FACS
study in the presence of liposomes free of tobramycin
to maintain the integrity of the bacterial cells allowed
the observation to be made that tobramycin is not
necessary for fusion to occur.
The lipid-mixing assay con¢rms that the increased
£uorescence incorporated into bacterial population
observed with liposomal-PKH2-GL is mainly a con-
tribution of fusion, but not aggregation. As men-
tioned above, the lipid-mixing assay is based on £uo-
rescence resonance energy transfer between the
headgroup of NBD and Rh [15]. Dilution of £uores-
cent lipids from liposomes into the bacterial mem-
branes could either occur through a process of mem-
brane fusion or through transfer of individual
molecules. It have been shown that NBD-PE and
Rh-PE are non-exchangeable [15,18,19], suggesting
that the interaction observed involves membrane fu-
sion. The non-exchangeable nature of Rh-PE and
NBD-PE were also con¢rmed in this study. When
a mixture of Rh/NBD-labeled Fluidosomes and
non-labeled Fluidosomes was incubated at 37‡C for
4 h, there was no signi¢cant £uorescence change. In
principle, aggregation of liposomes to bacteria can
also be ruled out because it does not involve lipid
dilution [15,18,19]. Hence fusion between bacteria
and Fluidosomes resulting in dilution of £uidosomal
lipids into bacterial membrane would be increasing
the distance between NBD and Rh and thus decreas-
ing the energy transfer e⁄ciency. It is therefore ex-
pected that fusion would lead to an increase in NBD
emission and a decrease for rhodamine. A clear fu-
sion pattern is shown in Fig. 4, where rhodamine
£uorescence intensity decreased and NBD intensity
increased as the incubation time increased. Similar
£uorescence emission scan (an increase in the NBD
emission and a decrease in rhodamine emission) re-
sulted from a fusion of liposomes with sperm cells
has recently been observed by Garrett and co-work-
ers [22]. The observed £uorescence changes were not
due to possible biodegradation since there was no
signi¢cant rhodamine £uorescence decrease when
rhodamine emission was monitored under rhodamine
excitation at 530 nm instead of NBD excitation at
475 nm by-passing RET (data not show).
Additionally, degrees of £uidosomal fusion with
both antibiotic-sensitive (P. aeruginosa 25619) and
resistant (P. aeruginosa 429) strains were compared
by kinetically monitoring the decrease of the rhod-
amine intensity at 590 nm (excitation at 475 nm) with
NBD/Rh-labeled Fluidosomes. A substantial rhod-
amine signal decrease was observed at 37‡C for
P. aeruginosa 25619. On the other hand, rhodamine
£uorescence slowly decreased for P. aeruginosa 429.
The degree of fusion is therefore correlated with the
predicted permeability and MIC values of both
strains as shown in Table 1. In a control experiment
under 4‡C, there was no signi¢cant decrease in Rh
intensity for both strains in presence of Fluidosomes.
The ability of Fluidosomes to increase penetration
of antibiotics in bacterial cells by a fusion mechanism
would be dependent on the TC and negative charge
of liposomal phospholipids [10,11]. At body temper-
ature, the liposomal phospholipids are in equilibrium
between the gel and £uid phases. Membrane merging
could be possible due to the formation of domains in
the liposomal membrane at temperatures equal or
above 37‡C. Due to membrane merging, the antibi-
otic could easily penetrate inside the bacteria allow-
ing the increased bactericidal e⁄cacy observed with
the drug, thus circumventing the normal pathway of
penetration [11,12]. Earlier studies have shown that
empty liposomes do not promote uptake of free to-
bramycin [12]. This is the ¢rst time that fusion be-
tween liposomes and bacterial cells based on low TC
of liposomes has been demonstrated to enhance the
e⁄cacy of the encapsulated therapeutic agent against
resistant strains [11,12]. Usually, drugs entrapped in
rigid liposomes may be more e¡ective than free drugs
in vivo, but they have generally low bactericidal ac-
tivity against extracellular bacteria in vitro [23^25].
The superior therapeutic e¡ect of liposome-encapsu-
lated drugs may result from liposomes being deliv-
ered to the infection site where they are degraded,
releasing their contents. Experimental models of in-
fections in which antimicrobial agents encapsulated
in rigid liposomes have been successful in both in
vivo and in vitro studies all involved infections of
cells of the mononuclear phagocyte system (MPS)
by facultative or obligate intracellular pathogens
[26,27]. In these studies, uptake of rigid liposomes
by phagocytes was essential to obtain a superior
therapeutic e¡ect. However, this is not the case
with Fluidosomes and e⁄cacy is displayed both in
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vitro and in vivo [11,12] against extracellular bacteria
and without the involvement of macrophages.
The treatment of bacterial infections is a growing
problem. Bacteria are becoming increasingly resistant
to a wide variety of antibiotics making their eradica-
tion more di⁄cult. The use of £uid liposomes for the
treatment of persistent or di⁄cult to treat infections
could be an answer to this growing problem of resis-
tance. Fluidosomes possess a unique bactericidal ac-
tivity against resistant strains and can be used with
di¡erent drugs (unpublished data). The present work
strongly suggests a fusion process between liposomal
and bacterial membranes to explain the bactericidal
e⁄cacy of Fluidosomes that has been demonstrated
in previous studies [11,12]. This demonstration is
particularly striking since P. aeruginosa possesses
one of the most e⁄cient impermeability barrier
against antibiotics. The data con¢rm that Fluido-
somes are very promising for patients su¡ering
from infections hard to treat that resist conventional
antibiotic therapy. Pre-clinical and clinical studies
are in progress to test the e⁄cacy of Fluidosomes
in the treatment of cystic ¢brosis. Many other appli-
cations of Fluidosomes are currently in progress.
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